TD Asset Management Inc Grows Stock Position in Chemed Corporation $CHE

Posted by Brenda Bartman on Jun 5th, 2026

TD Asset Management Inc lifted its stake in Chemed Corporation (NYSE:CHE – Free Report) by 7.5% during the 4th quarter, Holdings Channel reports. The institutional investor owned 324,546 shares of the company’s stock after buying an additional 22,715 shares during the period. TD Asset Management Inc’s holdings in Chemed were worth $138,860,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CHE. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Chemed by 2,444,879.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after buying an additional 5,549,876 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Chemed by 122.7% in the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after buying an additional 275,423 shares during the period. Norges Bank purchased a new position in shares of Chemed in the fourth quarter worth about $76,067,000. AQR Capital Management LLC increased its holdings in shares of Chemed by 160.9% in the second quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock worth $97,893,000 after buying an additional 123,982 shares during the period. Finally, M&T Bank Corp increased its holdings in shares of Chemed by 10,291.1% in the fourth quarter. M&T Bank Corp now owns 85,934 shares of the company’s stock worth $36,768,000 after buying an additional 85,107 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $431.70 on Friday. The stock’s 50 day simple moving average is $408.07 and its two-hundred day simple moving average is $424.45. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The stock has a market cap of $5.73 billion, a price-to-earnings ratio of 23.53, a PEG ratio of 1.60 and a beta of 0.54. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $565.66.

Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business’s revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the firm posted $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s payout ratio is presently 13.08%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada boosted their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a report on Sunday, May 31st. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Chemed currently has an average rating of “Hold” and a consensus target price of $501.50.

Read Our Latest Analysis on Chemed

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.